$Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer.$

Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer.

PURPOSE: The aim of this prospective, phase II trial was to determine the response of muscle-invasive bladder cancer (MIBC) to concurrent chemoradiotherapy of weekly gemcitabine with 4 weeks of radiotherapy (RT; GemX). PATIENTS AND METHODS: Fifty patients with transitional cell carcinoma, stage T2-3...

Full description

Bibliographic Details
Main Authors:	Choudhury, A, Swindell, R, Logue, J, Elliott, P, Livsey, J, Wise, M, Symonds, P, Wylie, J, Ramani, V, Sangar, V, Lyons, J, Bottomley, I, McCaul, D, Clarke, N, Kiltie, A, Cowan, R
Format:	Journal article
Language:	English
Published:	2011

Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer.

Similar Items